Developing and evaluating live CME sessions for family physicians on cancer and heredity: An RCT.

Live genetic continuing medical educational meetings for general practitioners: A double blind, randomised controlled trial of effectiveness.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27614

Enrollment

Registered

2012-03-12

Start date

2011-12-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

genetics, general practice, general practitioners (GPs), cancer, continuing educational meetings (CME), simulation patients, randomized controlled trial (RCT).

Interventions

Live accredited genetic continuing medical education (CME) meetings lasting approximately 4 hours during single evening sessions. GPs are able to randomly sign up for the live genetic CME meetings on

Eligibility

Inclusion criteria

Inclusion criteria: To be eligible for the study, Dutch GPs are required to work full- or part-time in a family practice setting. GPs are not required to comfortless use the internet, however a computer with internet access is necessary to access the online and login accessible genetic CME questionnaires.

Exclusion criteria

Exclusion criteria: GPs are excluded if they are unwilling or unable to participate in either randomly assigned study group. GPs outside the provinces of Noord Holland and Limburg in the Netherlands. The live genetic CME sessions are only held in these provinces and because we wish to not have selection bias and high validity of our testresults.

Design outcomes

Primary

Measure	Time frame
Knowledge on skills of genetics (such as how to refer and to whom) is assessed immediately before the intervention, one month after the intervention and 3 months later by mail linked to an online questionnaire. Skills and attitude is assessed through non anonymous live simulation patient contact in general practice shortly before the intervention, one month after the intervention and 3 months later. The participants in the control groups are visited by the simulation patients at the same time, they participated in the live genetic CME after all the live visits by the simulation patients and questionnaires are done. The non anonymous simulationpatients were instructed to tell the GPs once in the practice room they are there for the project, it is therefore "semi anonymous" because of logistic reasons.	—

Measure

Time frame

Knowledge on skills of genetics (such as how to refer and to whom) is assessed immediately before the intervention, one month after the intervention and 3 months later by mail linked to an online questionnaire. Skills and attitude is assessed through non anonymous live simulation patient contact in general practice shortly before the intervention, one month after the intervention and 3 months later. The participants in the control groups are visited by the simulation patients at the same time, they participated in the live genetic CME after all the live visits by the simulation patients and questionnaires are done. The non anonymous simulationpatients were instructed to tell the GPs once in the practice room they are there for the project, it is therefore "semi anonymous" because of logistic reasons.

—

Secondary

Measure	Time frame
Participants are also one month after the intervention. 3 months later the intervention group is further assessed for applicability of the acquired knowledge in daily genetic patient care.	—

Contacts

Public ContactElisa Houwink

Postbus 7057

e.houwink@vumc.nl+31 (0)20 4446446

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)